 SAN FRANCISCO, June 11, 2021 PRNewswire -- Invitae NYSE: NVTA, a leading medical genetics company, today announced the appointment of Roxi Wen as its chief financial officer, effective June 21, 2021. Wen brings decades of success as a senior financial executive where she scaled global technology and medical technology companies. 